Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status

BACKGROUND: Chromogenic in situ hybridization (CISH) is emerging as a practical, cost-effective, and valid alternative to fluorescent in situ hybridization in testing for gene alteration, especially in centers primarily working with immunohistochemistry (IHC). METHODS: We assessed Her-2/neu alterati...

Descripción completa

Detalles Bibliográficos
Autores principales: Madrid, Manuelito A, Lo, Raymundo W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549176/
https://www.ncbi.nlm.nih.gov/pubmed/15318940
http://dx.doi.org/10.1186/bcr915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549176/
https://www.ncbi.nlm.nih.gov/pubmed/15318940
http://dx.doi.org/10.1186/bcr915

Ejemplares similares